Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis

Critical Pathways in Cardiology

Volumn 9, Issue 3, 2010, Pages 116-125

  Boden, William E ^a   Cherr, Gregory S ^a   Eagle, Kim A ^b   Cannon, Christopher P ^c   Califf, Robert M ^d   Hirsch, Alan T ^e   Alberts, Mark J ^f   Criqui, Michael ^g   Creager, Mark A ^c   Massaro, Joseph M ^h   D'agostino, Ralph B ⁱ   Steg, P Gabriel ^j   Bhatt, Deepak L ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h BOSTON UNIVERSITY   (United States)

ⁱ HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^j INSERM   (France)

more..

Author keywords

atherosclerosis; cardiovascular intervention; cardiovascular outcomes; secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR PROCEDURES; CARDIOVASCULAR RISK; CAROTID ANGIOPLASTY; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE REGISTRY; FEMALE; HEART CATHETERIZATION; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HIGH RISK POPULATION; HUMAN; INTERVENTION STUDY; KAPLAN MEIER METHOD; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; STROKE; SYMPTOM; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED STATES;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THROMBOSIS; TREATMENT OUTCOME;

EID: 77956430497     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e3181e7f93e     Document Type: Article

References (44)

1. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92:657-671.
2. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111:3481-3488.
3. World Health Organization. The Top Ten Causes of Death. Geneva: World Health Organization; 2008.
4. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
5. Newman AB, Shemanski L, Manolio TA, et al. The Cardiovascular Health Study Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538-545.
6. Lichtman JH, Krumholz HM, Wang Y, et al. Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular Project. Circulation. 2002;105:1082-1087.
7. Vliegenthart R, Hollander M, Breteler MM, et al. Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study. Stroke. 2002;33:462-465. (Pubitemid 34123388)
8. Ohman EM, Bhatt DL, Steg PG, et al. The REduction of Atherothrombosis for Continued Health (REACH) registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006;151:786e1-786 e10.
9. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180-189.
10. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197-1206.
11. Eagle KA, Hirsch AT, Califf RM, et al. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the United States: insights from the REACH registry. Crit Pathw Cardiol. 2009;8:91-97.
12. Stenestrand U, Lindback J, Wallentin L. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA. 2006;296: 1749-1756.
13. Bavry AA, Kumbhani DJ, Rassi AN, et al. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006;48:1319-1325.
14. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
15. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273: 1421-1428.
16. Ferreira-Gonzalez I, Permanyer-Miralda G, Heras M, et al. Patterns of use and effectiveness of early invasive strategy in non-ST-segment elevation acute coronary syndromes: an assessment by propensity score. Am Heart J. 2008;156:946-953, 953 e2.
17. Fox KA, Anderson FA Jr, Dabbous OH, et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart. 2007;93:177-182.
18. Ederle J, Featherstone RL, Brown MM. Randomized controlled trials comparing endarterectomy and endovascular treatment for carotid artery stenosis: a Cochrane systematic review. Stroke. 2009;40:1373-1380.
19. Mas JL, Trinquart L, Leys D, et al. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008;7:885-892.
20. de Donato G, Setacci C, Deloose K, et al. Long-term results of carotid artery stenting. J Vasc Surg. 2008;48:1431-1440; discussion 1440-1441.
21. Bosiers M, Peeters P, Deloose K, et al. Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry). J Cardiovasc Surg (Torino). 2005;46:241-247.
22. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007; 45(suppl S):S5-S67. (Pubitemid 46151680)
23. Ploeg AJ, Lardenoye JW, Vrancken Peeters MP, et al. Contemporary series of morbidity and mortality after lower limb amputation. Eur J Vasc Endovasc Surg. 2005;29:633-637.
24. Taylor SM, Kalbaugh CA, Blackhurst DW, et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients. J Vasc Surg. 2005;42:227-235.
25. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the Management of Patients with STElevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction, writing on behalf of the 2004 Writing Committee. Circulation. 2008;117:296-329.
26. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116:e148-e304.
27. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463-e654.
28. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577-617. (Pubitemid 43732031)
29. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008;39:1647-1652.
30. Steinberg BA, Steg PG, Bhatt DL, et al. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol. 2007;99:1212-1215.
31. Mehta RH, Roe MT, Chen AY, et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med. 2006;166:2027-2034.
32. Lee HY, Cooke CE, Robertson TA. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm. 2008;14:271-280.
33. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidencebased secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203-212.
34. Cheng E, Chen A, Vassar S, et al. Comparison of secondary prevention care after myocardial infarction and stroke. Cerebrovasc Dis. 2006;21:235-241.
35. Cheng EM, Jolly D, Jones LA, et al. Modest improvement in risk factor control after admission for a stroke or transient ischemic attack. J Stroke Cerebrovasc Dis. 2005;14:174-178.
36. Ruland S, Raman R, Chaturvedi S, et al. Awareness, treatment, and control of vascular risk factors in African Americans with stroke. Neurology. 2003;60: 64-68.
37. Rehring TF, Sandhoff BG, Stolcpart RS, et al. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg. 2005;41:816-822.
38. Ness J, Aronow WS, Newkirk E, et al. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. J Gerontol A Biol Sci Med Sci. 2005;60:255-257.
39. Kasai T, Miyauchi K, Kurata T, et al. Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy. Int J Cardiol. 2007;114:210-217.
40. Kubota N, Kasai T, Miyauchi K, et al. Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention. Heart Vessels. 2008;23:35-39.
41. Spencer FA, Frederick PD, Goldberg RJ, et al. Use of combination evidencebased medical therapy prior to acute myocardial infarction (from the National Registry of Myocardial Infarction-4). Am J Cardiol. 2005;96:922-926.
42. Alexander D, Ou FS, Roe MT, et al. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE). Am Heart J. 2008;156:606-612.
43. Tricoci P, Roe MT, Mulgund J, et al. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge. Arch Intern Med. 2006;166:806-811.
44. Yan AT, Yan RT, Tan M, et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J. 2007;154:1108-1115.